Epilepsy Pathway Innovation in Africa
Epilepsy affects over 50 million people across the world. 80% of these people live in low to middle income countries. There is a very high rate of epilepsy in Africa, where misunderstanding and stigma lead to limited diagnoses and treatment.
Epilepsy Pathway Innovation in Africa (EPINA) is a research team based in Oxford that has partnered with leading institutions in Kenya, Ghana and Tanzania. Working in these countries, EPINA aims to:
- better understand the impact of stigma on people with epilepsy
- improve epilepsy knowledge to improve help-seeking and treatment
- develop an app to help healthcare workers to diagnose epilepsy
- develop portable electroencephalograms to diagnose epilepsy in rural settings
- improve medication adherence through text messaging.
EPINA could dramatically change the lives of people with epilepsy in sub Saharan Africa. If successful, we will use our knowledge to ensure that similar work is carried out across other low and middle-income countries.
Visit the EPInA website here: https://epina.web.ox.ac.uk
Subscribe to the EPInA newsletter here: https://epina.web.ox.ac.uk/article/newsletters
Nightmare frequency is a risk factor for suicidal ideation during the COVID-19 pandemic.
Bolstad CJ. et al, (2024), J Sleep Res
Ultrahigh frequencies of peripherally matured LGI1- and CASPR2-reactive B cells characterize the cerebrospinal fluid in autoimmune encephalitis
Theorell J. et al, (2024), Proceedings of the National Academy of Sciences, 121
The natural recovery of visuospatial neglect: a systematic review and meta-analysis
Overman MJ. et al, (2024)
Neuro‐immune interactions in health and disease: Insights from FENS‐Hertie 2022 Winter School
Binder LB. et al, (2024), European Journal of Neuroscience